CCCC · C4 Therapeutics, Inc.

$4.03 -0.18 (-4.28%) At close · Aug 20

Market Cap

$495.79M

123.03M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Andrew J. Hirsch	President & Chief Executive Officer	$694,925	$100,000	$710,730	$848,007	$573,313	$14,000	$2,940,975
Leonard Reyno	Chief Medical Officer	$597,740	$100,000	$276,978	$330,300	$322,780	$14,000	$1,641,798
Kendra R. Adams	Chief Financial Officer	$506,825	$75,000	$276,978	$330,300	$273,686	$14,000	$1,476,789

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Andrew J. Hirsch	President & Chief Executive Officer	$665,000	—	$755,854	$3,402,805	$402,325	$13,800	$5,239,784
Leonard Reyno	Chief Medical Officer	$572,000	—	$268,277	$1,208,343	$251,680	$13,800	$2,314,100
Kendra R. Adams	Chief Financial Officer	$485,000	—	$268,277	$1,217,997	$213,400	$12,815	$2,197,489

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Andrew J. Hirsch	President & Chief Executive Officer	$639,000	—	$470,832	$2,333,189	$333,878	$13,200	$3,790,099
Leonard Reyno	Chief Medical Officer	$262,660	$268,415	$214,550	$709,596	$209,000	$10,506	$1,674,727
Stewart Fisher	Chief Scientific Officer	$479,232	—	$147,420	$711,925	$182,020	$13,320	$1,533,917
Kendra R. Adams	Chief Financial Officer	$404,553	—	$138,800	$488,956	$171,000	$7,289	$1,210,598

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Scott N. Boyle	Chief Business Officer	$398,718	$100,000	$558,698	$2,682,524	$159,123	$14,937	$3,914,000
Stewart Fisher	Chief Scientific Officer	$460,800	—	$558,698	$1,888,838	$184,320	$12,222	$3,104,878
Andrew J. Hirsch	President & Chief Executive Officer	$614,400	—	$1,624,400	—	$337,920	$18,675	$2,595,395

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Lauren A. White	Chief Financial Officer	$220,269	$60,000	—	$3,696,534	$102,800	$6,000	$4,085,603
Stewart Fisher	Chief Scientific Officer	$434,700	$54,000	—	$3,094,174	$200,000	$6,000	$3,788,874
Adam S. Crystal	M.D., Ph.D. Chief Medical Officer	$434,700	$61,000	—	$2,862,803	$200,000	$6,000	$3,564,503
Jolie M. Siegel	Chief Legal Officer & Secretary	$414,000	—	—	$2,765,041	$190,400	$6,000	$3,375,441
Andrew J. Hirsch	President & Chief Executive Officer	$579,600	—	—	—	$366,600	$6,000	$952,200
William T. McKee	Former Chief Financial Officer	—	—	—	—	—	$348,403	$348,403

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Andrew J. Hirsch	President & Chief Executive Officer	$167,850	—	—	$20,659,713	$98,800	$5,608	$20,931,971
Marc A. Cohen	Interim Chief Executive Officer	—	—	—	$9,063,399	—	$69,500	$9,132,899
William T. McKee	Former Chief Financial Officer	—	—	—	$1,025,271	—	$1,074,474	$2,099,745
Adam S. Crystal	M.D., Ph.D. Chief Medical Officer	$409,750	$61,000	—	$941,770	$184,800	$6,000	$1,603,320
Stewart Fisher	Chief Scientific Officer	$379,663	$54,000	—	$963,530	$186,500	$6,000	$1,589,693
Andrew Phillips	Former President & Chief Executive Officer	$94,500	—	—	—	—	$523,775	$618,275

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Andrew Phillips	Former President & Chief Executive Officer	$520,000	—	—	$3,377,316	$260,000	$36,359	$4,193,675
Adam S. Crystal	M.D., Ph.D. Chief Medical Officer	$344,250	$100,000	—	$1,118,835	$120,488	$6,373	$1,689,946
Stewart Fisher	Chief Scientific Officer	$340,313	—	—	—	$119,110	$6,330	$465,753
Marc A. Cohen	Interim Chief Executive Officer	—	—	—	—	—	—	—
Andrew J. Hirsch	President & Chief Executive Officer	—	—	—	—	—	—	—
William T. McKee	Chief Financial Officer	—	—	—	—	—	—	—

Executive changes

Person	Role	Change	Effective	Filed
Kendra R. Adams	principal accounting officer	Appointed	2026-05-15	2026-05-15
Mark Mossler	Chief Accounting Officer	Terminated	2026-05-15	2026-05-15
Bruce Downey	director	Retired	2025-04-10	2025-04-14
Steven L. Hoerter	director	Appointed	2024-11-19	2024-11-20
Paige Mahaney, Ph.D.	Chief Scientific Officer	Appointed	2024-10-28	2024-10-15
Stewart Fisher, Ph.D.	Chief Scientific Officer	Retired	2024-10-28	2024-10-15
Stephen Fawell	director	Appointed	2024-08-29	2024-09-03
Malcolm Salter	Director	Resigned	2024-08-29	2024-09-03
Bruce Downey	Chair of the Board	Resigned	2024-06-07	2024-06-10
Ron Cooper	Chair of the Board	Appointed	2024-06-07	2024-06-10
Ron Cooper	director	Appointed	2024-06-07	2024-06-10
Glenn Dubin	Director	Resigned	2024-06-07	2024-06-10
Owen P. Hughes, Jr.	director	Appointed	2023-11-16	2023-11-20
Mark Mossler	Chief Accounting Officer and principal accounting officer	Appointed	2023-09-18	2023-09-05
Kendra Adams	Chief Financial Officer, Treasurer and principal financial officer	Appointed	2023-09-18	2023-09-05
Lauren White	Chief Financial Officer, Treasurer, principal financial officer and principal accounting officer	Resigned	2023-09-15	2023-09-05
Leonard M.J. Reyno, M.D.	Chief Medical Officer	Appointed	2023-07-10	2023-06-20
Adam S. Crystal, M.D., Ph.D.	Chief Medical Officer	Resigned	2023-02-24	2023-02-02
Laura Bessen, M.D.	director	Appointed	2022-07-29	2022-08-02
Donna Grogan, M.D.	director	Appointed	2022-07-29	2022-08-02
Elena Prokupets	director	Resigned	2022-03-10	2022-03-16
Utpal Koppikar	director	Appointed	2022-03-16	2022-03-16
Laura J. Wahlberg	VP, Finance and Corporate Controller and principal accounting officer	Resigned	2021-05-28	2021-05-20
William T. McKee	principal accounting officer on an interim basis	Appointed	—	2021-05-20
Lauren White	principal accounting officer	Appointed	2021-06-21	2021-05-20

Key facts CIK 1662579 CUSIP 12529R107 13F (30d) 145 filings 140 filers Visit website Investor relations